Indication
Hepatitis A Vaccine
1 clinical trial
2 products
Product
HavrixClinical trial
A Randomized, Double-blind, Multi-center, Active-controlled, Parallel-designed, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Korean Healthy Children Aged 12~23 MonthsStatus: Completed, Estimated PCD: 2019-06-24